Evidence map›Paper›PMID 35429254›Full record

ArticleAMB Express2022

Differentiation of an Iranian resistance chickpea line to Ascochyta blight from a susceptible line using a functional SNP.

Kiyanoush Zangene, Abbasali Emamjomeh, Farhad Shokouhifar, Mojtaba Mamarabadi, Nafiseh Mehdinezhad

Abstract read
In one paragraph

Article in AMB Express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kiyanoush ZangeneDepartment of Plant Breeding and Biotechnology, Faculty of Agriculture, University of Zabol, Zabol, Iran.
Abbasali EmamjomehDepartment of Plant Breeding and Biotechnology (PBB), Faculty of Agriculture, University of Zabol, Zabol, Iran. aliimamjomeh@uoz.ac.ir.
Farhad ShokouhifarResearch Center for Plant Sciences, Ferdowsi University of Mashhad, Mashhad, Iran. shokouhifar@um.ac.ir.
Mojtaba MamarabadiDepartment of Plant Protection, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran.
Nafiseh MehdinezhadDepartment of Plant Breeding and Biotechnology, Faculty of Agriculture, University of Zabol, Zabol, Iran.

Funding

University of Zabol IR-UOZ-GR-2874
6 · The paper itself

Abstract

Identification of resistant sources to Ascochyta blight (AB) has been considered as a main purpose in most chickpea breeding programs. Achievements to molecular markers related to resistance to Ascochyta rabiei allows selection programs to be developed more accurately and efficiently. The aim of this study was to investigate the applicability of a functional SNP in differentiating Iranian resistant cultivars to be used in selection programs. Amplification of SNP-containing fragment with specific primer pair and its sequencing resulted in tracking and determining the allelic pattern of SNP18, SNP18-2147, SNP18-2491 and SNP18-2554 loci belong to GSH118 gene in ILC263 (sensitive) and MCC133 (resistant) chickpea lines. Mutations in SNP18 and SNP18-2147 occur at the protein level at positions 499 and 554. Bioinformatics studies have shown that the GSH118 gene is a Lucien-rich repeat receptor kinases (LRR-RKs) and encodes a membrane protein which can be involved in recognizing microorganisms and initiating immune signaling pathways in plants. Additional studies to determine the function of this gene and its interaction with other proteins can be effective in gaining more knowledge about the molecular basis of resistance against AB.

Indexed as

Cell surface receptorsKinase domainLRR-based cell surface interaction networkMarker assisted selection

Identifiers

PMID35429254
PMCPMC9013395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.